Ausbiz Capital is now SureStone Capital. Same team, same ABN and AFS authorisations.

ASX: CYGCoventry Group LtdIndustrials

Coventry Group Q1 EBITDA Up 87% to $5.4m on Cost Cuts

Coventry Group reported unaudited Q1 FY27 sales of $100.1m and Pre AASB16 EBITDA of $5.4m, up 87%, as gross margin rose to 42.0% and operating costs fell.

By Digifin Pty Ltd · About this coverage

Key Points

  • Unaudited Q1 FY27 Sales of $100.1m, up 1.3% on the prior corresponding period
  • Pre AASB16 EBITDA of $5.4m, up 87% from $2.9m
  • Gross margin up approximately 50 basis points to 42.0%; operating costs down $1.5m
  • Gross leverage ratio just under 5x at 30 September 2026, from a peak of 10x
  • Strategic review ongoing; divisional offers judged not to represent appropriate value
Coventry Group Ltd (ASX:CYG)

About Coventry Group (ASX:CYG)

Coventry Group Ltd is an ASX-listed industrial distribution company headquartered in Melbourne. It supplies fasteners, industrial products and fluid systems to trade and industrial customers in Australia and New Zealand.

Coventry Group (ASX:CYG) released a first-quarter trading update showing a third consecutive quarter of EBITDA improvement, which it attributes to a lower cost base and stronger gross margin, while its strategic review continues.

Unaudited Q1 FY27 Sales were $100.1m, up 1.3% on Q1 FY26, and Pre AASB16 EBITDA was $5.4m, up 87% from $2.9m, on a normalised basis before Significant Items and at constant currency. Gross margin improved by approximately 50 basis points to 42.0%, and operating costs were $1.5m (3.9%) lower, which the company links to its $10m cost-out program. Trade Distribution sales rose 6.9% to $62.5m, while Fluid Systems sales fell 6.9% to $37.6m, reflecting project timing and softer activity in some end markets. The gross leverage ratio has fallen from a peak of 10x at March 2026 to just under 5x at 30 September 2026. The NAB financing facility was recently extended by 12 months to August 2028, the Group is in compliance with its September 2026 quarter covenant obligations, and liquidity was $13.8m.

On a reported basis, Q1 EBITDA would be approximately $0.12m lower. The Board judged non-binding indicative offers for individual divisions not to represent appropriate value, the strategic review remains ongoing, and the release gives no FY27 earnings guidance.

Back to all ASX Company News

Source: Coventry Group Ltd (ASX:CYG), 16 October 2026. Summary content supplied by Digifin Pty Ltd.

News summary only, not financial advice. It does not consider your objectives, financial situation or needs.

Friday, 16 October 2026

Also summarised today

All ASX Company News
ASX: AEFFinancials

Australian Ethical Q1 FUM at $14.43 Billion, Super Flows Up

Australian Ethical had FUM of $14.43 billion at 30 September 2026, down from $14.50 billion, as investment outflows outweighed $0.13 billion of super net flows.

16 Oct, 8:27 am AEDT
ASX: AHCHealth Care

Austco Agrees to Acquire Monitoring Software Firm RTM

Austco agreed to buy RTM for approximately $9.44 million upfront plus an uncapped earnout, its first software acquisition, due to complete in December.

16 Oct, 9:16 am AEDT
ASX: DYLEnergy

Deep Yellow Withdraws Q4 2026 FID Target for Tumas

Deep Yellow withdrew its Q4 2026 Final Investment Decision target for the Tumas uranium project, citing equity markets, while funded civil works continue.

16 Oct, 8:26 am AEDT
ASX: FRSMaterials

Forrestania Targets December Gold Start at Edna May

Forrestania Resources is targeting first ore at its Edna May plant in mid-December 2026, subject to final equipment, with Lake Johnston to follow in early 2027.

16 Oct, 8:33 am AEDT
ASX: HLOConsumer Discretionary

Helloworld Guides FY27 Underlying EBITDA of $78m-$84 million

Helloworld Travel expects FY27 Underlying EBITDA of $78m-$84 million, including $14 million from Crown Currency Exchange, after a flat first quarter of FY27.

16 Oct, 9:36 am AEDT
ASX: MYXHealth Care

Mayne Pharma Settles IMVEXXY Patent Case With Teva USA

Mayne Pharma settled its US IMVEXXY patent litigation with Teva, agreeing generic entry from 2 September 2032 with no payment, subject to court approval.

16 Oct, 9:43 am AEDT
ASX: PLSMaterials

PLS Approves A$1.9B P2000 Expansion at Pilgangoora

PLS took a final investment decision on its A$1.9B P2000 Project to lift Pilgangoora output to approximately 2.0Mtpa, with first production expected in CY29.

16 Oct, 8:17 am AEDT
ASX: SKCConsumer Discretionary

SkyCity Agrees Sale of The Grand Hotel for $221,000,000

SkyCity signed a conditional agreement to sell The Grand Hotel for $221,000,000, with settlement targeted for mid-December 2026 and proceeds used to repay debt.

16 Oct, 7:30 am AEDT

Announcement summaries are published each trading day. General advice only.

Copyright © 2026 SureStone Capital